<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Panaxadiol (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e>) is a purified <z:chebi fb="0" ids="26606">sapogenin</z:chebi> of ginseng <z:chebi fb="1" ids="26605">saponins</z:chebi>, which exhibits anticancer activity </plain></SENT>
<SENT sid="1" pm="."><plain>Epigallocatechin <z:chebi fb="0" ids="16918">gallate</z:chebi> (<z:chebi fb="0" ids="4806">EGCG</z:chebi>), a major <z:chebi fb="0" ids="23053">catechin</z:chebi> in green tea, is a strong botanical <z:chebi fb="11" ids="22586">antioxidant</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we investigated the possible synergistic anticancer effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:chebi fb="0" ids="4806">EGCG</z:chebi> on human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells and explored the potential role of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the synergistic activities </plain></SENT>
<SENT sid="3" pm="."><plain>Effects of selected compounds on HCT-116 and SW-480 human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells were evaluated by a modified trichrome stain cell proliferation analysis </plain></SENT>
<SENT sid="4" pm="."><plain>Cell cycle distribution and apoptotic effects were analyzed by flow cytometry after staining with PI/RNase or annexin V/PI </plain></SENT>
<SENT sid="5" pm="."><plain>Cell growth was suppressed after treatment with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> (10 and 20 µm) for 48 h </plain></SENT>
<SENT sid="6" pm="."><plain>When <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> (10 and 20 µm) was combined with <z:chebi fb="0" ids="4806">EGCG</z:chebi> (10, 20, and 30 µm), significantly enhanced antiproliferative effects were observed in both cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>Combining 20 µm of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> with 20 and 30 µm of <z:chebi fb="0" ids="4806">EGCG</z:chebi> significantly decreased S-phase fractions of cells </plain></SENT>
<SENT sid="8" pm="."><plain>In the apoptotic assay, the combination of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:chebi fb="0" ids="4806">EGCG</z:chebi> significantly increased the percentage of apoptotic cells compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> alone (p &lt; 0.01) </plain></SENT>
<SENT sid="9" pm="."><plain>The synergistic apoptotic effects were also supported by docking analysis, which demonstrated that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> and <z:chebi fb="0" ids="4806">EGCG</z:chebi> bound in two different sites of the annexin V protein </plain></SENT>
<SENT sid="10" pm="."><plain>Data from this study suggested that <z:mpath ids='MPATH_3'>apoptosis</z:mpath> might play an important role in the <z:chebi fb="0" ids="4806">EGCG</z:chebi>-enhanced antiproliferative effects of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PD</z:e> on human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
</text></document>